Why are some people more resilient to viruses than others? The answer has eluded scientists for centuries and, in the age of COVID-19, has come to represent one of the holy grails of biomedical research.
Thirty years after beginning her training as a postdoctoral scholar in the CU Boulder lab of Nobel laureate Thomas Cech, biochemist Jennifer Doudna on Wednesday won her own Nobel Prize for Chemistry for the co-development of the revolutionary genome editing tool CRISPR-Cas9